nivolumab,etigilimab
mereo biopharmaceuticalceutical,bms,marker therapeutics
['nivo', 'etigilimab', 'solid tumor', 'nivolumab', 'mereo ']
we are pleased to share updated clinical data for etigilimab + nivolumab in select recurrent advanced/metastatic solid tumors. view press release: #tigit 
Mereo is a clinical-stage company focused on developing therapies in oncology & #orphandrugs / #rarediseasetherapies for #rarediseases